We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

17 hedge funds and large institutions have $2.2M invested in Anixa Biosciences in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

6% more funds holding

Funds holding: 16 → 17 (+1)

0.03% more ownership

Funds ownership: 6.57% → 6.6% (+0.03%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

49% less capital invested

Capital invested by funds: $4.36M → $2.2M (-$2.15M)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$148K
2
Renaissance Technologies
Renaissance Technologies
New York
+$94.4K
3
Victory Capital Management
Victory Capital Management
Texas
+$21.1K
4
Bank of America
Bank of America
North Carolina
+$1.77K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$651

Top Sellers

Rank Fund Capital Flow
1
SFS
Strategic Financial Services
New York
-$83K
2
Morgan Stanley
Morgan Stanley
New York
-$9.7K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$4.63K
4
BlackRock
BlackRock
New York
-$3.27K
5
TRCT
Tower Research Capital (TRC)
New York
-$2.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.06M – – –
UBS Group
2
UBS Group
Switzerland
$543K +$148K +50,585 +17%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$162K – – –
BlackRock
4
BlackRock
New York
$128K -$3.27K -1,117 -1%
Northern Trust
5
Northern Trust
Illinois
$86K +$293 +100 +0.2%
Bank of New York Mellon
6
Bank of New York Mellon
New York
$63K -$4.63K -1,581 -4%
Renaissance Technologies
7
Renaissance Technologies
New York
$51K +$94.4K +32,216 New
SBH
8
Segall Bryant & Hamill
Illinois
$27K – – –
Morgan Stanley
9
Morgan Stanley
New York
$23K -$9.7K -3,310 -19%
RJA
10
Raymond James & Associates
Florida
$16K – – –
Wells Fargo
11
Wells Fargo
California
$13K +$331 +113 +1%
Victory Capital Management
12
Victory Capital Management
Texas
$12K +$21.1K +7,212 New
TRCT
13
Tower Research Capital (TRC)
New York
$8K -$2.8K -955 -16%
Bank of America
14
Bank of America
North Carolina
$7K +$1.77K +604 +15%
JP Morgan Chase
15
JP Morgan Chase
New York
$2K – – –
SFS
16
Strategic Financial Services
New York
– -$83K -25,250 Closed
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
– +$651 +222 New

ANIX Hedge Fund Activity: Q1 2020 in Review

17 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q1 2020, worth a combined $2.2M — down 49% from $4.36M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ANIX positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.

The largest buyer was UBS Group, adding an estimated $148K. The largest seller was Strategic Financial Services, exiting entirely with an estimated $83K sold.

  • 17 institutional investors held Anixa Biosciences (ANIX) as of Q1 2020, up from 16 in Q4 2019.
  • Funds reported $2.2M of Anixa Biosciences stock for Q1 2020, down 49% quarter-over-quarter.
  • 3 funds opened new Anixa Biosciences positions in Q1 2020 and 2 closed out, a net change of +1 holder.
  • The largest Anixa Biosciences buyer in Q1 2020 was UBS Group, an estimated $148K added.
  • The largest Anixa Biosciences seller in Q1 2020 was Strategic Financial Services, an estimated $83K sold.

Based on aggregated 13F filings for Q1 2020.